follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Sales at Celgene rise 17 percent in second quarter

By

Back to Top Comments Print

News You Can Use

Latest News

advertisement

Net product sales at pharmaceutical giant Celgene Corp. climbed to $1.56 billion in the second quarter of 2013, a 17 percent increase over the same period last year, according to the company's most recent earnings report.

In that same time, adjusted net income at the Summit-based company rose 20 percent, to $653 million. Total revenue also was up for the quarter, climbing to $1.59 billion, from $1.36 billion last year.

Celgene specializes in developing drugs to treat cancer and inflammatory diseases.

Reporter Mary Johnson is @mjohns422 on Twitter.

Mary Johnson

Mary Johnson

Mary Johnson is a staff reporter covering midsized and growth companies, as well as women in business. Mary lived in Fla., Texas, Conn. and N.Y. before moving to N.J. with her husband and infant son. Email her at maryj@njbiz.com. She is @mjohns422 on Twitter. Read her blog, Breaking Glass.

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top